Literature DB >> 11224361

The effect of dizocilpine (MK-801) on spatial and visual discrimination tasks in the rat.

T.K. Murray1, R.M. Ridley, M.F. Snape, A.J. Cross.   

Abstract

The present experiments investigated the effect of the non-competitive N-methyl-d-aspartate (NMDA)-receptor antagonist, dizocilpine (MK-801) (0.075mg/kg) on acquisition and reversal of either a spatial or a visual, appetitively rewarded, simultaneous discrimination task in a Y-maze. The experimental design for the spatial and the visual discriminations was identical, the only difference between the tasks being the nature of the stimulus. Dizocilpine had not effect on acquisition of the spatial task although, when this task was reversed, dizocilpine-treated rats took significantly more trials to reach criterion. On the visual task, dizocilpine impaired both acquisition and reversal. Thus, systemic administration of dizocilpine did not produce a specific spatial learning impairment. The fact that dizocilpine impaired reversal but not acquisition in the spatial task argues against a global performance deficit. Although both the acquisition and reversal phases of the experiment make equal sensory and motor demands on the animal, reversal involves specific learning processes that may be disrupted by dizocilpine.

Entities:  

Year:  1995        PMID: 11224361

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  10 in total

1.  Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning.

Authors:  Gemma L Dalton; Liya M Ma; Anthony G Phillips; Stan B Floresco
Journal:  Psychopharmacology (Berl)       Date:  2011-03-08       Impact factor: 4.530

2.  A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists.

Authors:  Sophie Dix; Gary Gilmour; Slavinka Potts; Janice W Smith; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

3.  NMDA receptor antagonism impairs reversal learning in developing rats.

Authors:  Kathryn K Chadman; Deborah J Watson; Mark E Stanton
Journal:  Behav Neurosci       Date:  2006-10       Impact factor: 1.912

4.  The Effects of Poria cocos on Rho Signaling-Induced Regulation of Mobility and F-Actin Aggregation in MK-801-Treated B35 and C6 Cells.

Authors:  Yi-Chyan Chen; Chang-Ti Lee; Fu-Ming Tsai; Mao-Liang Chen
Journal:  Behav Neurol       Date:  2022-07-12       Impact factor: 3.112

5.  Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.

Authors:  Guy A Higgins; Theresa M Ballard; Michel Enderlin; Marie Haman; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

6.  Medial prefrontal administration of MK-801 impairs T-maze discrimination reversal learning in weanling rats.

Authors:  Deborah J Watson; Mark E Stanton
Journal:  Behav Brain Res       Date:  2009-07-28       Impact factor: 3.332

7.  Spatial and visual discrimination reversals in adult and geriatric rats exposed during gestation to methylmercury and n-3 polyunsaturated fatty acids.

Authors:  Elliott M Paletz; Jeremy J Day; Margaret C Craig-Schmidt; M Christopher Newland
Journal:  Neurotoxicology       Date:  2007-05-06       Impact factor: 4.294

8.  mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task.

Authors:  Amber L LaCrosse; Brian T Burrows; Rachel M Angulo; Phoebe R Conrad; Sarah M Himes; Nordia Mathews; Scott A Wegner; Sara B Taylor; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2014-06-29       Impact factor: 4.530

9.  Intrahippocampal administration of an NMDA-receptor antagonist impairs spatial discrimination reversal learning in weanling rats.

Authors:  Deborah J Watson; Mark E Stanton
Journal:  Neurobiol Learn Mem       Date:  2009-02-25       Impact factor: 2.877

10.  Touchscreen testing reveals clinically relevant cognitive abnormalities in a mouse model of schizophrenia lacking metabotropic glutamate receptor 5.

Authors:  Ariel M Zeleznikow-Johnston; Thibault Renoir; Leonid Churilov; Shanshan Li; Emma L Burrows; Anthony J Hannan
Journal:  Sci Rep       Date:  2018-11-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.